GT199100031A - Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas. - Google Patents

Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas.

Info

Publication number
GT199100031A
GT199100031A GT199100031A GT199100031A GT199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A
Authority
GT
Guatemala
Prior art keywords
asthma
arthritis
treatment
azabencimidazoles
related diseases
Prior art date
Application number
GT199100031A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199100031A publication Critical patent/GT199100031A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GT199100031A 1990-05-09 1991-05-09 Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas. GT199100031A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52119990A 1990-05-09 1990-05-09

Publications (1)

Publication Number Publication Date
GT199100031A true GT199100031A (es) 1992-10-30

Family

ID=24075786

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199100031A GT199100031A (es) 1990-05-09 1991-05-09 Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas.

Country Status (28)

Country Link
EP (1) EP0533695B1 (enExample)
JP (1) JPH0678340B2 (enExample)
CN (1) CN1057839A (enExample)
AP (1) AP224A (enExample)
AT (1) ATE112567T1 (enExample)
AU (1) AU642265B2 (enExample)
BG (1) BG97059A (enExample)
BR (1) BR9106433A (enExample)
CA (1) CA2080476A1 (enExample)
DE (1) DE69104481T2 (enExample)
DK (1) DK0533695T3 (enExample)
ES (1) ES2061247T3 (enExample)
FI (1) FI925053A7 (enExample)
GT (1) GT199100031A (enExample)
HU (1) HUT62894A (enExample)
IE (1) IE911553A1 (enExample)
IL (1) IL98075A0 (enExample)
MA (1) MA22151A1 (enExample)
MY (1) MY105512A (enExample)
NO (1) NO924290D0 (enExample)
NZ (1) NZ238089A (enExample)
PE (1) PE26691A1 (enExample)
PT (1) PT97616A (enExample)
RO (1) RO109450B1 (enExample)
TW (1) TW205549B (enExample)
WO (1) WO1991017163A1 (enExample)
YU (1) YU81191A (enExample)
ZA (1) ZA913497B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
US6372770B1 (en) 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
EP1077967B1 (en) * 1998-05-12 2002-12-04 Wyeth Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2015039036A2 (en) 2013-09-13 2015-03-19 Cortendo Ab(Publ) Novel cytochrome p450 inhibitors and their method of use
CN105348182B (zh) * 2014-08-24 2018-04-13 复旦大学 2‑烷氧基苯甲酰芳胺类化合物及其药物用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8822170D0 (en) * 1988-09-21 1988-10-26 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HU9203496D0 (en) 1993-01-28
AP224A (en) 1992-10-27
EP0533695A1 (en) 1993-03-31
WO1991017163A1 (en) 1991-11-14
PE26691A1 (es) 1991-10-21
MY105512A (en) 1994-10-31
CA2080476A1 (en) 1991-11-10
EP0533695B1 (en) 1994-10-05
NO924290L (no) 1992-11-06
BG97059A (bg) 1993-12-24
FI925053L (fi) 1992-11-06
ATE112567T1 (de) 1994-10-15
YU81191A (sh) 1994-06-10
AU642265B2 (en) 1993-10-14
BR9106433A (pt) 1993-05-04
CN1057839A (zh) 1992-01-15
RO109450B1 (ro) 1995-02-28
DE69104481D1 (de) 1994-11-10
IE911553A1 (en) 1991-11-20
AP9100259A0 (en) 1991-07-31
AU7867191A (en) 1991-11-27
NZ238089A (en) 1992-10-28
FI925053A0 (fi) 1992-11-06
JPH0678340B2 (ja) 1994-10-05
DE69104481T2 (de) 1995-02-09
NO924290D0 (no) 1992-11-06
IL98075A0 (en) 1992-06-21
TW205549B (enExample) 1993-05-11
MA22151A1 (fr) 1991-12-31
PT97616A (pt) 1992-03-31
DK0533695T3 (da) 1995-01-09
JPH05505619A (ja) 1993-08-19
ZA913497B (en) 1992-12-30
HUT62894A (en) 1993-06-28
FI925053A7 (fi) 1992-11-06
ES2061247T3 (es) 1994-12-01

Similar Documents

Publication Publication Date Title
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
ES2064667T3 (es) Derivados de 3-aminopiperidina y heterociclos relacionados que contienen nitrogeno.
UY27258A1 (es) Derivados de dihidro-benzo b 1, 4 diazepin-2-ona como antagonistas ii mglur2
DK0693073T3 (da) Bicykliske ansamyciner og deres anvendelse som antitumormidler
GT199100031A (es) Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas.
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
PA8524101A1 (es) 2-(4-PIRIDIL) AMINO-6-DIALCOXIFENIL-PIRIDO [2,3-d] PIRIMIDIN-7-ONAS
ECSP034796A (es) DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA ANTAGONISTAS I MGLUR2
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
DE69326977D1 (de) Morpholin und Thiomorpholin Tachykinin Rezeptorantagonisten
MX9305934A (es) Nuevo modificador de resistencia a drogas multiples.
ES2045110T3 (es) Mejoras en o relacionadas con antagonistas de leucotrienos.
GT199800205A (es) Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos.
ATE278673T1 (de) Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren
ES2058306T3 (es) Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas.
EE200200263A (et) Telomeeride G-kvadrupleksstruktuuri fikseerivad ühendid, nende kasutamine ja terapeutilised kombinatsioonid
DK0705100T3 (da) Terapeutiske substituerede guanidiner
SE9802729D0 (sv) Novel Compounds
MX9205219A (es) Un material de n-oxido de tramadol, enantiomeros, y composiciones del mismo, y su uso
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
ES2132401T3 (es) Tetrahidro-1h-benzazepinonas y hexahidroazepinonas como antagonistas selectivos del receptor colecistoquinina-b.
MX9302034A (es) Bencidazoles, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
MX9300409A (es) Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.
ES2063261T3 (es) 1-(3-(heteroarilmetoxi)fenil) alcanoles sustituidos y compuestos relacionados en el tratamiento de asma, artritis y enfermedades relacionadas.